Curis
CRIS
#11142
Rank
S$3.09 M
Marketcap
S$1.28
Share price
-8.26%
Change (1 day)
-40.93%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): S-$30.45

According to Curis's latest financial reports the company's current EPS (TTM) is S-$30.36. In 2025 the company made an earnings per share (EPS) of S-$30.36 an increase over its 2024 EPS that were of S-$179.37.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$30.450.29%
2025S-$30.36-83.07%
2024S-$179.37-22.15%
2023S-$230.40-26.17%
2022S-$312.0422.3%
2021S-$255.14-25.37%
2020S-$341.89-30.93%
2019S-$494.98-2.02%
2018S-$505.19
2016S-$1,148-10%
2015S-$1,276138.1%
2014S-$535.8040%
2013S-$382.72-25%
2012S-$510.2966.67%
2011S-$306.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.67-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.54-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$3.99-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.43-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$6.43-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$0.22-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA